Debbie Payne-Turner

11.3k total citations · 1 hit paper
14 papers, 770 citations indexed

About

Debbie Payne-Turner is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Debbie Payne-Turner has authored 14 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 10 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in Debbie Payne-Turner's work include Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Acute Myeloid Leukemia Research (5 papers). Debbie Payne-Turner is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Acute Myeloid Leukemia Research (5 papers). Debbie Payne-Turner collaborates with scholars based in United States, Canada and Netherlands. Debbie Payne-Turner's co-authors include Charles G. Mullighan, Jinghui Zhang, James R. Downing, Ching‐Hon Pui, Jing Ma, J. Racquel Collins-Underwood, Paul K. Brindle, Letha A. Phillips, Susan L. Heatley and Kenneth H. Buetow and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Debbie Payne-Turner

14 papers receiving 765 citations

Hit Papers

CREBBP mutations in relap... 2011 2026 2016 2021 2011 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CREBBP mutations in relapsed acute lymphoblastic leukaemia
    2011 433 citations Charles G. Mullighan, Jinghui Zhang et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debbie Payne-Turner United States 6 473 423 272 217 119 14 770
Renate Panzer‐Grümayer Austria 16 527 1.1× 404 1.0× 228 0.8× 226 1.0× 144 1.2× 35 766
R Panzer-Grümayer Austria 11 503 1.1× 373 0.9× 243 0.9× 212 1.0× 100 0.8× 13 753
Wolf-Dieter Ludwig Germany 9 393 0.8× 318 0.8× 168 0.6× 147 0.7× 96 0.8× 12 587
Sandra Heesch Germany 15 376 0.8× 368 0.9× 382 1.4× 119 0.5× 104 0.9× 21 777
Elena Eckroth United States 8 384 0.8× 331 0.8× 198 0.7× 159 0.7× 210 1.8× 15 638
Lisa J. Russell United Kingdom 16 855 1.8× 716 1.7× 189 0.7× 408 1.9× 99 0.8× 30 1.0k
Julia A. Meyer United States 8 292 0.6× 218 0.5× 336 1.2× 152 0.7× 101 0.8× 10 605
E. Renate Panzer‐Grümayer Austria 13 441 0.9× 365 0.9× 113 0.4× 163 0.8× 73 0.6× 19 564
Jan Zuna Czechia 21 813 1.7× 739 1.7× 316 1.2× 232 1.1× 155 1.3× 61 1.1k
Linda Holmfeldt United States 8 281 0.6× 275 0.7× 393 1.4× 106 0.5× 141 1.2× 14 740

Countries citing papers authored by Debbie Payne-Turner

Since Specialization
Citations

This map shows the geographic impact of Debbie Payne-Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie Payne-Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie Payne-Turner more than expected).

Fields of papers citing papers by Debbie Payne-Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie Payne-Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie Payne-Turner. The network helps show where Debbie Payne-Turner may publish in the future.

Co-authorship network of co-authors of Debbie Payne-Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie Payne-Turner. A scholar is included among the top collaborators of Debbie Payne-Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie Payne-Turner. Debbie Payne-Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rampersaud, Evadnie, David S. Ziegler, Ilaria Iacobucci, et al.. (2019). Germline deletion of ETV6 in familial acute lymphoblastic leukemia. Blood Advances. 3(7). 1039–1046. 18 indexed citations
2.
Iacobucci, Ilaria, Chunxu Qu, Laura J. Janke, et al.. (2018). Multiplex CRISPR/Cas9-Based Genome Editing of Mouse Hematopoietic Stem Cells Recapitulates Acute Erythroid Leukemia and Identifies Therapeutic Targets. Blood. 132(Supplement 1). 5–5. 2 indexed citations
3.
Roberts, Kathryn G., Yung‐Li Yang, Debbie Payne-Turner, et al.. (2017). Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL.. SHILAP Revista de lepidopterología. 1(20). 1657–1671. 80 indexed citations
4.
Roberts, Kathryn G., Yung‐Li Yang, Debbie Payne-Turner, et al.. (2015). Abstract PR02: Investigating the use of tyrosine kinase inhibitors in Ph-like ALL.. Clinical Cancer Research. 21(17_Supplement). PR02–PR02. 1 indexed citations
5.
Dang, Jinjun, Lei Wei, Jeroen de Ridder, et al.. (2015). PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia. Blood. 125(23). 3609–3617. 53 indexed citations
6.
Roberts, Kathryn G., Deqing Pei, Dario Campana, et al.. (2014). Outcomes of Children With BCR-ABL1 –Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease. Journal of Clinical Oncology. 32(27). 3012–3020. 165 indexed citations
7.
Roberts, Kathryn G., Yung‐Li Yang, Debbie Payne-Turner, et al.. (2014). Functional Analysis of Kinase-Activating Fusions in Ph-like Acute Lymphoblastic Leukemia. Blood. 124(21). 786–786. 2 indexed citations
8.
Holmfeldt, Linda, Paolo Vignali, Debbie Payne-Turner, et al.. (2013). Genomic- and Transcriptomic Profiling Of Acute Lymphoblastic Leukemia With Dicentric Chromosomes. Blood. 122(21). 234–234. 1 indexed citations
9.
Churchman, Michelle L., Jonathan Low, Debbie Payne-Turner, et al.. (2013). High Content Screening Identifies Synthetic Lethality Of Retinoid Receptor Agonists In IKZF1-Mutated BCR-ABL1 positive Acute Lymphoblastic Leukemia. Blood. 122(21). 172–172. 1 indexed citations
10.
Mullighan, Charles G., Jinghui Zhang, Lawryn H. Kasper, et al.. (2011). CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature. 471(7337). 235–239. 433 indexed citations breakdown →
11.
Houghton, Peter J., Christopher L. Morton, Min H. Kang, et al.. (2010). Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing program. Pediatric Blood & Cancer. 55(6). 1224–1226. 4 indexed citations
12.
Mullighan, Charles G., Jinghui Zhang, Lawryn H. Kasper, et al.. (2010). CREBBP Mutations In Relapsed Acute Lymphoblastic Leukemia. Blood. 116(21). 413–413. 7 indexed citations
13.
Collins-Underwood, J. Racquel, Nidal Boulos, Debbie Payne-Turner, et al.. (2010). The Role of Dominant-Negative IKAROS Mutations In the Pathogenesis and Treatment Responsiveness of BCR-ABL1 positive Acute Lymphoblastic Leukemia. Blood. 116(21). 540–540. 2 indexed citations
14.
Lock, Richard B., Hernán Carol, Peter Houghton, et al.. (2008). 192 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the anti-CD19-DM4 conjugated antibody SAR3419. European Journal of Cancer Supplements. 6(12). 61–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renate Panzer‐Grümayer Breakdown of academic impact, for papers by R Panzer-Grümayer Breakdown of academic impact, for papers by Wolf-Dieter Ludwig Breakdown of academic impact, for papers by Sandra Heesch Breakdown of academic impact, for papers by Elena Eckroth Breakdown of academic impact, for papers by Lisa J. Russell Breakdown of academic impact, for papers by Julia A. Meyer Breakdown of academic impact, for papers by E. Renate Panzer‐Grümayer Breakdown of academic impact, for papers by Jan Zuna Breakdown of academic impact, for papers by Linda Holmfeldt
Rankless by CCL
2026